Cargando…
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening
A small library of new angelicin derivatives was designed and synthesized with the aim of bypassing the side effects of trimethylangelicin (TMA), a promising agent for the treatment of cystic fibrosis. To prevent photoreactions with DNA, hindered substituents were inserted at the 4 and/or 6 position...
Autores principales: | Vaccarin, Christian, Gabbia, Daniela, Franceschinis, Erica, De Martin, Sara, Roverso, Marco, Bogialli, Sara, Sacchetti, Gianni, Tupini, Chiara, Lampronti, Ilaria, Gambari, Roberto, Cabrini, Giulio, Dechecchi, Maria Cristina, Tamanini, Anna, Marzaro, Giovanni, Chilin, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570109/ https://www.ncbi.nlm.nih.gov/pubmed/36232826 http://dx.doi.org/10.3390/ijms231911528 |
Ejemplares similares
-
Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators
por: Laselva, Onofrio, et al.
Publicado: (2018) -
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis
por: Franceschinis, Erica, et al.
Publicado: (2022) -
New TMA (4,6,4′-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease
por: Tupini, Chiara, et al.
Publicado: (2022) -
Differential Effects of Angelicin Analogues on NF-κB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells
por: Lampronti, Ilaria, et al.
Publicado: (2017) -
β-Sitosterol Reduces the Expression of Chemotactic Cytokine Genes in Cystic Fibrosis Bronchial Epithelial Cells
por: Lampronti, Ilaria, et al.
Publicado: (2017)